2Zlotnik A, Moore TA. Cytokine production and requirements during T- cell development. Curt Opin Immunol 1995;7:206.
3Lopez CH, Varas A, Sacedon R, et al. Stromal cell - derived factor I/CXCR4 signaling is critical for early human T- cell development.Blood 2002;99:546 - 554.
4Ma F, Yang F, Kaneko A, et al. Cytokine requirement for the development of T - lymphoid lineage potential in clonal lymphohaematopoietic progenitors in vitro. Br J Haematol 2000;11:1170- 1179.
5Barcena A, Galy AH, Punnonenet J, et al. Lymphoid and myeloid differentiation of fetal liver CD34 + lineage - cells in human thymic organ culture. J Experim Med 1994; 180:123- 132.
6Plum J, Smedt MD, Defresne MP, et al. Human CD34^+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood 1994;84:1587 - 1593.
7Weekx SFA, Snoeck HW, Offner F, et al. Generation of T cells from adult human hematopoietic stem cells and progenitors in a fetal thymic organ culture system: stimulation by tumor necrosis factor-α. Blood 2000;95:2806-2812.
8Alan PK, Roodman ST, Margaret E, et al. Development of a method of thymocyte differentiation of bone marrow- enriched CD34^+ CD38^- cells in postnatal allogeneic cultured thymic epithelia to evaluate immunodeficiency disorders. Stem Cells 1996; 14:702-713.
9Margaret ER, Ruiz, Freeman J, et al. Arrest of in vitro T cell differentiation of normal bone marrow- derived CD34 + stem cells with thymie epithelial fragments from children with AIDS. Stem Cells 1996; 14:533 - 547.
10Margaret ER, Roodman ST, Bouhasin JD, et al. T cell differentiation/maturation of CD34^+ stem cells from HIV - seropositive hemophiliacs in cultured thymic epithelial fragments. Stem Cells 1996;14:132 - 145.
2Murphy FP, Coven TR, Burack LH, et al. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apotosis [J]. Arch Dermatol, 1999,135:1495-1502.
3Gottlieb SL, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte[J]. Pathogenic Basis, Nat Med,1995,1:442-447.
4Bata-Csorgo Z, Hammmerberg C, Voorhees JJ, et al. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia[J]. J Invest Dermal, 1995,105: 89-94.
5Nickoloff BJ, Wrone-Smith T, Bonish B, et al. Response of murine and normal human skin to injection of allogeneic blood derived psoriatic immunocytes[ J]. Arch Dermatol, 1999,135: 546-552.
6Brian J. The immunologic and genetic basis of psoriasis[J] .Arch Dermatol, 1999,135:1104-1110.
7Gilhar A, David M, Ullmann Y, et al. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice[J] .J Invest Dermatol, 1997,109:283-288.
8Nickoloff B J, Wrone-Smith T. Superantigens, autoantigens, and pathogenic T cells in psoriasis[J] .J Invest Dermatol, 1998,110:459-460.
9LisaMA, Maki O. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interlerkin-2, and tumor necrosis factor-α, defining TC1 (Cytotoxic T lymphocyte)and TH1 effector population[ J ]. J Invest Derma
10Schon MP, Detmar M, Parker CM. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med, 1997,3: 183-188.
